SEQENSgroup
Seqens held on 8 June 2021 its 2nd Scientific Commitee. On this occasion, our new solid state capabilities and services addressing our customers’s…
Read moreThe Labcom HitCat (High-Throughput Catalysis center) was inaugurated in partnership with the CNRS in the Seqens’Lab. Their common objective is to develop innovative…
Read moreAfter a full year of R&D studies, SEQENS has officially launched the project to build a new paracetamol production unit, in partnership with…
Read moreAcetylSalicylic Acid (ASA better known as Aspirin) is one of the most popular Non-Steroidal Anti-Inflammatory Drugs (NSAID) in the world. First used…
Read moreProfessor Patrick Couvreur, Emeritus Professor of Pharmacy at Paris-Saclay University, has a world-renowned expertise in the design of new nanomedicines for the treatment…
Read moreSingaporean chemical industry Global Business Reports (GBR) launches its 2021 Singapore Chemicals edition in a digital interactive format. This report describes the performance of…
Read moreThe construction of the Novawood biomass cogeneration plant is well underway! On June 3rd, an important step in the project was taken…
Read moreSeqens participates in the 3rd Franco-German Technology Dialogue on the resilience of European healthcare industries. The meeting was held today under the chairmanship of…
Read moreDID YOU KNOW? The applications of our products contribute to some of the 17 United Nations SDGs. The applications of our products contribute…
Read moreAlganelle is an innovative biotechnology company with a disruptive technology at the forefront of microalgae synthetic biology, providing a safer, high quality raw material…
Read more